Sökresultat

He was selling carpets on Mårtenstorget in Lund, applying for all kinds of jobs and answered an advert from the Department of Clinical Immunology, Lund University, for a lab technician job. He didn´t get the job. Instead he was asked if he wanted to start a Ph.D. A few weeks ago immunology professor William Agace was elected a member of the Royal Swedish Academy of Sciences. He invited me to his c

https://www.medicine.lu.se/article/carpets-market-academy-professor - 2025-10-01

800 people in Sweden are currently on the waiting list to receive donated organs, but there are too few organs. Nearly one person dies each week in Sweden while on the waiting list. How can this lack of donor organs in Sweden be solved? Researchers Darcy Wagner, Department of Experimental Medical Science, and Sandra Lindstedt Ingemansson, Department of Clinical Science Lund and Skåne University Ho

https://www.medicine.lu.se/article/translational-research-developing-new-methods-prevent-organ-rejection-and-growing-new-organs-lab - 2025-10-01

Swedish health care delivers good results, yet we hear every day about the health crisis and its consequences. Now, representatives of academia and health care have grown tired of the crises and started the think tank Health Care and Science with the goal of contributing to solutions and spreading good ideas. – We want to create better health care by strengthening the relationship between health c

https://www.medicine.lu.se/article/think-tank-seeks-solutions-health-crisis - 2025-10-01

Contagion spreads in various ways, with airborne viruses being especially difficult to protect oneself against. Norovirus, or the winter vomiting bug as it is sometimes known, is just such a virus. Carl-Johan Fraenkel, infectious disease and healthcare hygiene specialist, is currently defending his thesis at Lund University, looking at various aspects of how norovirus spreads in hospitals. Althoug

https://www.medicine.lu.se/article/researchers-track-spread-norovirus-hospitals - 2025-10-01

For a decade now, the Rehabilitation Medicine research group’s work on spinal cord injuries (SCI’s) has had a far-reaching impact. In many areas, this is research at the global cutting edge; not least, in terms of following the same group of individuals as they live – and age – with spinal cord injuries. Research group leader Jan Lexell is preparing to flex the group’s academic muscles further in

https://www.medicine.lu.se/article/lund-research-spinal-cord-injuries-continues-have-global-impact - 2025-10-01

Directly after birth, the immune system completes production of a subtype of antibody-producing immune cells, B-1, that are to last for a lifetime. No more B1-cells are formed after that point. However, these cells are self-reactive – they produce not only antibodies against foreign substances, but also against the body’s own substances, and it is unclear why the immune system allows for the devel

https://www.medicine.lu.se/article/how-self-reactive-immune-cells-are-allowed-develop - 2025-10-01

Chronic myeloid leukaemia (CML) is a slowly progressing form of blood cancer that attacks the blood-forming cells in the bone marrow. The condition requires lifelong treatment that can cause severe side effects. Rebecca Warfvinge maps stem cells in patients in the hope of identifying predictive markers for how the patient will react to therapy. She has now received an award of USD 20,000 from the

https://www.medicine.lu.se/article/tailored-therapy-chronic-myeloid-leukaemia - 2025-10-01

When then medical student Jonatan Wistrand met a patient who was seriously ill with cancer a few years ago he was extremely moved. On November 29 he defended his doctoral thesis at Lund University with his thesis “The doctor as the patient – documentary and literary statements during the 20th and 21st century”. “I did my training in medical school but worked temporarily during the summer as an ass

https://www.medicine.lu.se/article/situation-conflict-when-doctor-becomes-patient - 2025-10-01

Mobile apps can help patients with neurological disorders manage their symptoms better and stimulate people into having a healthier lifestyle. This is indicated by interdisciplinary research conducted at the research centre CASE at Lund University, which has been published in the scientific journal Disability and Rehabilitation: Assistive Technology. “The results are significant to future developm

https://www.medicine.lu.se/article/improved-symptom-management-and-healthier-lifestyle-help-apps - 2025-10-01

Einar Smith is being awarded the Swedish Savings Bank Foundation scholarship for his thesis. A prospective study which demonstrates that the metabolite ergothioneine, independent of other risk factors, can be linked to a reduced risk of cardiovascular disease and premature death. The study is published in BMJ Heart. Einar Smith is being awarded the Swedish Savings Bank Foundation scholarship for b

https://www.medicine.lu.se/article/connection-between-markers-healthy-diet-and-reduced-risk-cardiovascular-disease-resulted-scholarship - 2025-10-01

Para-athletics is growing in strength worldwide. However, behind the Paralympics that we watch on TV from our sofas there are greater challenges than those related to results. A new thesis from Lund University demonstrates how Paralympic athletes run the risk of sustaining injuries as a result of strict training as well as illnesses caused by their disability. To ensure that the athletes stay heal

https://www.medicine.lu.se/article/paralympic-athletes-double-struggle-against-injuries-and-diseases - 2025-10-01

The European Research Council today announced the winners of its latest Consolidator Grant competition: 301 top scientists and scholars across Europe. Funding for these researchers, part of the Horizon 2020 research and innovation programme, is worth in total EUR 600 million. Filipe Pereira at Lund University in Sweden is one of the 89 selected researchers, and will be awarded an ERC Consolidator

https://www.medicine.lu.se/article/prestigious-erc-grant-innovative-immunotherapy-research - 2025-10-01

Zaal Kokaia, Professor within the Department of Clinical Sciences and Director of Lund Stem Cell Center, has been awarded Georgia’s most prestigious scientific prize - the National Prize in Science. The award comes as a result of his outstanding contribution to world class scientific research and was presented to Prof. Kokaia at a ceremony in the Presidential Palace, Tbilisi, by the Georgian Presi

https://www.medicine.lu.se/article/prestigious-scientific-prize-awarded-director-lund-stem-cell-center - 2025-10-01

A few weeks ago The Huntington Disease Center in Lund, Sweden, welcomed researchers, clinicians and representatives from patient organizations in the Nordic countries to the second Nordic Huntington Disease Research Meeting in Lund. Among the prominent visitors were Patrick Weydt, representative of the European Huntington Disease Network and Astri Arnesen, President of The European Huntington Asso

https://www.medicine.lu.se/article/european-huntington-heights-met-lund-summit - 2025-10-01

The risk of experiencing financial difficulties due to medical care costs is relatively small in Sweden. This is revealed in a recent report from the World Health Organization, where researchers from Lund University have investigated the extent to which Swedish households are financially affected by using the health care system. “The Swedish health care system protects residents from catastrophic

https://www.medicine.lu.se/article/who-report-healthcare-sweden-among-most-affordable-europe - 2025-10-01

Researchers at Lund University in Sweden have used a neuropeptide to successfully reduce seizure-like activity in tissue from patients with drug-resistant epilepsy. One challenge facing researchers who study brain diseases is that for understandable reasons it is difficult to obtain human brain tissue for experiments. For that reason, experimental models are used, such as rodent studies, but one p

https://www.medicine.lu.se/article/peptide-reduced-epileptic-seizures-human-brain-tissue - 2025-10-01

Researchers at Lund University in Sweden have developed a new hydrogel based on the body’s natural peptide defense. It has been shown to prevent and treat infections in wounds. The formulation kills multi-resistant bacteria, something that is increasing in importance with antibiotic resistance growing globally. “The ability to effectively heal wounds is key for our survival in evolutionary terms.

https://www.medicine.lu.se/article/next-generation-wound-gel-treats-and-prevents-infections - 2025-10-01

European complementologists have joined forces and created CORVOS. A highly coordinated and innovative research and training program for early stage researchers in immunology and infectious diseases. Lund University is a part of the initiative. The major aims of CORVOS are the discovery of therapeutic ways to support or inhibit the action of complement and to interfere with its abuse by pathogens

https://www.medicine.lu.se/article/corvos-european-joint-doctorate-programme-immunology - 2025-10-01

Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. Immunotherapy strengthens the immune system so that it can fight cancer more effectively. One type of immunotherapy is checkpoint therapy, that targets the checkpoin

https://www.medicine.lu.se/article/b-cells-linked-effective-cancer-immunotherapy - 2025-10-01

In a major study of hereditary breast cancer, a global network of researchers (including some from Lund University) has identified over 350 faults in DNA that increase an individual’s risk of developing the disease. The researchers believe that these faults can affect as many as 190 genes. Published in Nature Genetics, a scientific journal, the results are said to be the thus far most comprehensiv

https://www.medicine.lu.se/article/major-study-gives-most-comprehensive-map-breast-cancer-risk - 2025-10-01